The Sutureless Microanastomosis

Authors:

Abstract
It has recently become clinically feasible to extract highly concentrated fibrinogen from the patient's own blood. In combination with commercial thrombin this fibrinogen/thrombin compound can be used as tissue adhesive, hemostatic agent and intravascular embolizer. In this presentation the authors describe a new end-to-side and side-to-side microanastomosis using this autologous "fibrin glue" (Fibrinkleber) in stead of suture material. The advantages of the new technique consist of: • Simplicity • Greatly reduced OR time • Increased patency rate • Can be done without operating microscope

This publication has 2 references indexed in Scilit: